Medicare's AI Prior Authorization Trial Cuts Medical Services Fast
Medicare deployed AI to pre-approve patient care and saw an immediate, significant drop in medical services utilized by beneficiaries.
Medicare has begun testing artificial intelligence as a tool for conducting prior authorizations, a process that determines whether specific medical treatments and services will be covered, and the experiment quickly produced a sharp decline in the volume of care patients received, according to a MarketWatch report.
The initiative is part of a broader federal effort to curb what officials characterize as wasteful medical spending within the Medicare program, which covers tens of millions of elderly and disabled Americans. Prior authorization has long been a contested mechanism in health care, requiring providers to obtain insurer approval before delivering certain treatments — a system critics argue delays or denies necessary care.
Read more Texas Brothers Get 15-Year Terms for Armed Crypto Robbery →
The rapid reduction in services following AI deployment raises immediate questions about whether the technology is filtering out genuinely unnecessary procedures or creating new barriers to care that patients actually need. Medical advocacy groups and patient rights organizations have previously warned that automated decision-making in health coverage determinations can compound existing inequities and move too quickly for adequate human oversight.
The test represents one of the more consequential applications of AI within a major government health program to date. How Medicare evaluates outcomes — distinguishing between eliminated waste and denied necessary care — will likely shape whether the approach is expanded, modified, or abandoned. Policymakers and health care providers are watching closely as the results come into sharper focus.
Continue reading at MarketWatch.com
